^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Adrenal Cortex Carcinoma |
| Drug: | carboplatin (Tubulin polymerization promoter) + etoposide IV (Topoisomerase II inhibitor) + Lysodren (mitotane) (Steroid receptor inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Adrenocortical carcinoma: Systemic therapy for locoregional unresectable/metastatic adrenocortical carcinoma…preferred regimens…Carboplatin + etoposide + mitotane
